Myriad Genetics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $803.8M
Liabilities Breakdown FY2013
Total Liabilities: $75.2M
Asset Breakdown
Total Assets: $803.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $104.1M | 13.0% |
| Accounts Receivable | $94.3M | 11.7% |
| Inventory | $5.0M | 0.6% |
| Property, Plant & Equipment | $27.6M | 3.4% |
| Goodwill | $56.9M | 7.1% |
| Intangible Assets | $13.3M | 1.7% |
| Other Assets | $502.5M | 62.5% |
Liabilities Breakdown
Total Liabilities: $75.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $18.1M | 24.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $57.1M | 75.9% |